Search research articles
Contact Us
Filters
Showing results (21-30 of 112) with videos related to
Page
of 12
Sort By:
American Journal of Clinical Oncology
|
December 1, 1994
Tumor lysis syndrome in nonhematologic malignancies. Report of a case and review of the literature
P Drakos, J Bar-Ziv, R Catane
Harefuah
|
July 1, 1990
[Somatostatin analogue in the treatment of neuroendocrine gut tumors]
R Ben Yosef, B Glaser, R Catane
Advances in Biotechnological Processes
|
January 1, 1989
Monoclonal antibodies in cancer diagnosis and therapy
N Epstein, E Warner-Efrati, R Catane
Cancer Treatment Reports
|
March 1, 1977
New steroidal alkylating agents in advanced stage D carcinoma of the prostate
A Mittelman, R Catane, G P Murphy
Journal of Neuro-Oncology
|
September 1, 1988
Early and delayed neurotoxicity of mitoxantrone and doxorubicin following subarachnoid injection
T Siegal, E Melamed, U Sandbank, et al.
Journal of Medicine
|
January 1, 1983
Treatment of febrile granuloycytopenic cancer patients receiving antineoplastic therapy with a combination of carbenicillin, cefazolin and gentamicin
J Halpern, R Catane, T Sacks, et al.
Tumori
|
May 1, 1981
DTIC and actinomycin D with and without C. parvum immunotherapy in advanced malignant melanoma
J Halpern, R Catane, S Biran, et al.
Gynecologic Oncology
|
May 1, 1985
High-dose metoclopramide as an antiemetic in patients receiving cis-platinum-based combination chemotherapy
E Gez, R Catane, L Pfau, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1980
The rediscovery of DON (6-diazo-5-oxo-L-norleucine)
D L Kisner, R Catane, F M Muggia
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 22, 2006
Problems of opioid availability and accessibility across Europe: ESMO tackles the regulatory causes of intolerable and needless suffering
N I Cherny, R Catane, P A Kosmidis
Page
of 12
Search research articles
Search
Showing results (21-30 of 112) with videos related to
Sort By:
Page
of 12
American Journal of Clinical Oncology
|
December 1, 1994
Tumor lysis syndrome in nonhematologic malignancies. Report of a case and review of the literature
P Drakos, J Bar-Ziv, R Catane
Harefuah
|
July 1, 1990
[Somatostatin analogue in the treatment of neuroendocrine gut tumors]
R Ben Yosef, B Glaser, R Catane
Advances in Biotechnological Processes
|
January 1, 1989
Monoclonal antibodies in cancer diagnosis and therapy
N Epstein, E Warner-Efrati, R Catane
Cancer Treatment Reports
|
March 1, 1977
New steroidal alkylating agents in advanced stage D carcinoma of the prostate
A Mittelman, R Catane, G P Murphy
Journal of Neuro-Oncology
|
September 1, 1988
Early and delayed neurotoxicity of mitoxantrone and doxorubicin following subarachnoid injection
T Siegal, E Melamed, U Sandbank, et al.
Journal of Medicine
|
January 1, 1983
Treatment of febrile granuloycytopenic cancer patients receiving antineoplastic therapy with a combination of carbenicillin, cefazolin and gentamicin
J Halpern, R Catane, T Sacks, et al.
Tumori
|
May 1, 1981
DTIC and actinomycin D with and without C. parvum immunotherapy in advanced malignant melanoma
J Halpern, R Catane, S Biran, et al.
Gynecologic Oncology
|
May 1, 1985
High-dose metoclopramide as an antiemetic in patients receiving cis-platinum-based combination chemotherapy
E Gez, R Catane, L Pfau, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1980
The rediscovery of DON (6-diazo-5-oxo-L-norleucine)
D L Kisner, R Catane, F M Muggia
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 22, 2006
Problems of opioid availability and accessibility across Europe: ESMO tackles the regulatory causes of intolerable and needless suffering
N I Cherny, R Catane, P A Kosmidis
Page
of 12